Skip to main content

Want a detailed portfolio tracker?

Evommune (EVMN) P/E

Evommune (EVMN) P/E from Mar 31, 2026 to Jul 20, 2026. The TTM Evommune (EVMN) P/E is -19.16. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Evommune (EVMN)

YearP/EChange
2026-19.16N/A

Comparison Evommune (EVMN) P/E with competitors

Evommune (EVMN) P/E is -19.16.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.39%
FGENFibroGen Inc0.24-101.25%
CHRSCoherus Biosciences Inc0.85-104.43%
FBIOFortress Biotech Inc0.95-104.95%
ORMPOramed Pharmaceuticals Inc1.50-107.84%
AGENAgenus Inc3.01-115.70%
INVAInnoviva Inc3.15-116.46%
VXRTVaxart Inc3.55-118.52%
CRMDCorMedix Inc3.63-118.93%
CVACCureVac N.V.4.45-123.20%
GLPGGalapagos NV4.86-125.35%
SRPTSarepta Therapeutics Inc4.88-125.47%
ABEOAbeona Therapeutics Inc5.39-128.11%
ABUSArbutus Biopharma Corp5.60-129.20%
ZVRAZevra Therapeutics Inc5.89-130.72%
SPROSpero Therapeutics Inc6.23-132.50%
CGENCompugen Ltd6.31-132.94%
RIGLRigel Pharmaceuticals6.87-135.86%
SLXNSilexion Therapeutics Corp7.30-138.07%
OMEROmeros Corporation9.26-148.31%
AUPHAurinia Pharmaceuticals Inc9.58-150.01%
PLXProtalix BioTherapeutics Inc10.89-156.83%
ACADAcadia Pharmaceuticals Inc11.73-161.20%
TBPHTheravance Biopharma Inc12.26-163.98%
ADMAAdma Biologics Inc12.42-164.80%
HRMYHarmony Biosciences Holdings Inc13.82-172.11%
SABSSAB Biotherapeutics Inc14.14-173.76%
NAGENiagen Bioscience Inc14.82-177.32%
INCYIncyte Corp15.82-182.56%
REGNRegeneron Pharmaceuticals Inc15.86-182.74%
PBYIPuma Biotechnology Inc17.32-190.35%
CPRXCatalyst Pharmaceuticals Inc17.44-191.00%
EXELExelixis Inc17.54-191.51%
TGTXTG Therapeutics Inc18.97-198.96%
MDXGMimedx Group Inc20.55-207.24%
XOMAXOMA Royalty Corp22.87-219.36%
ARGXArgen X SE24.30-226.79%
CTMXCytomX Therapeutics Inc24.82-229.52%
XOMAOXOMA Royalty Corp25.34-232.25%
HALOHalozyme Therapeutics Inc25.62-233.70%
XOMAPXOMA Royalty Corp25.67-233.95%
VRTXVertex Pharmaceuticals Inc27.99-246.08%
RPRXRoyalty Pharma plc - Class A28.69-249.69%
SLNOSoleno Therapeutics Inc29.02-251.40%
ASNDAscendis Pharma A/S30.09-256.99%
LGNDLigand Pharmaceuticals Inc - Class B37.91-297.82%
APLSApellis Pharmaceuticals Inc39.02-303.61%
BMRNBiomarin Pharmaceutical Inc42.21-320.26%
KRYSKrystal Biotech Inc45.34-336.60%
ONCBeiGene Ltd69.54-462.86%
PHARPharming Group N.V.75.03-491.48%
TECHBio-Techne Corp101.96-632.02%
VCELVericel Corp109.92-673.57%
ALNYAlnylam Pharmaceuticals Inc117.96-715.54%
GMABGenmab140.29-832.03%
TLXTelix Pharmaceuticals Ltd162.15-946.11%
CORTCorcept Therapeutics Inc212.86-1210.69%